Reports April 2019

 

Enlightened New Alcohol Research: SHAAP/SARN report

Scottish Health Action on Alcohol Problems (SHAAP) and the Scottish Alcohol Research Network (SARN) have published a report covering six presentations at an event held last year in Edinburgh. Download the Enlightened New Alcohol Research Symposium report [pdf] here | Alcohol Policy UK, UK

Improving Lives: Helping Workless Families indicators 2019

'Improving Lives: Helping Workless Families' indicator data used to track progress in tackling disadvantages affecting families’ and children’s outcomes. [Chapter 5 considers parental drug and alcohol dependency] | DWP, UK

Cannabis Use, Harms and Perceived Risks among Canadian Students

This report compiles results from provincial and national SDUS to provide a pan-Canadian perspective on baseline trends before legalization in cannabis use, associated harms and perceived risks among Canadian students in grades 7 through 12. It is intended to inform policy makers, substance use treatment and prevention program developers, researchers, health professionals and those working with youth | CCSA, Canada

Numbing the Pain: Survivors’ voices of childhood sexual abuse and addiction (PDF)

One in Four’s new report, Numbing the Pain: Survivors’ voices of childhood sexual abuse and addictionhighlights sexual abuse as an underlying trauma for many people who experience substance abuse addiction | One in four, UK

Psychostimulants play a major role in fatal strokes among young adults

The study by researchers from the National Drug and Alcohol Research Centre (NDARC) at UNSW Sydney found that from 2009–2016, psychostimulant users constituted nearly a fifth of the 279 cases of fatal stroke in adults aged 15–44 years. The majority of the deaths had evidence of psychostimulant consumption immediately prior to the fatal stroke | NDARC, Australia

Withdrawal Management Services in Canada: The National Treatment Indicators Report (PDF)

In March 2019, CCSA released the seventh and current National Treatment Indicators Report. It features information from 2015–2016, and for the first time includes provincial data on withdrawal-related hospital admissions | CCSA, Canada

National Opioid Pharmacotherapy Statistics Annual Data collection (NOPSAD) 2018

On a snapshot day in 2018, just over 50,000 clients received pharmacotherapy treatment for their opioid dependence at 2,852 dosing points across Australia. There were 3,168 authorised prescribers of opioid pharmacotherapy drugs | AIHW, Australia

Scottish Crime and Justice Survey 2017/18: Main Findings

This summary presents a range of key findings from the 2017/18 Scottish Crime and Justice Survey | Scottish Government, UK

Room for improvement: How drug consumption rooms save lives (PDF)

A new report by Jarryd Bartle, a drug policy consultant and university lecturer, calls for Britain to introduce life-saving Drug Consumption Rooms | Adam Smith Institute, UK

Hepatitis C - Annual Epidemiological Report for 2017

European surveillance data show a 10 percent decrease in newly reported hepatitis C cases between 2016 and 2017. However, with more than 31,000 recorded cases in 2017, diagnoses remain at a high level in the European Union and European Economic Area (EU/EEA) | ECDC, Sweden

Psychotropic Substances - Technical Report

On an annual basis the Psychotropics Control Section of the INCB Secretariat publishes a technical report that provides an overview of the world wide licit manufacture, export, import, stocks and consumption of substances controlled under the Convention on Psychotropic Substances of 1971. In addition to providing specific figures for movements of many scheduled substances the report includes commentary on emerging and ongoing trends in the licit market for psychotropic substances under international control | INCB, USA

Liver disease profiles: April 2019 update

This update of the liver disease profiles data tool includes new data on persons aged 18 years and over in drug misuse treatment who inject drugs and are receiving a hepatitis C test, for 2017 to 2018 | PHE, UK

National Prison Drugs Strategy

The Prison Drugs Strategy sets out our ambition to tackle drugs by restricting supply, reducing demand and building recovery. This mirrors the 3 strands of the HM Government Drug Strategy and, through a comprehensive approach, offers the best opportunity to reduce the levels of drug misuse in our prisons | MoJ and HMPPS, UK

Hepatitis C deaths fall by 16 per cent between 2015 and 2017

Deaths from serious hepatitis C related liver disease fell from 380 to 319, thanks to new curative treatments. But while England has exceeded the World Health Organization’s (WHO) target to reduce hepatitis C related mortality by 10% by 2020, challenges still exit to eliminate the disease in this country | PHE, UK

A changing landscape: stop smoking services and tobacco control in England (PDF)

[From March 15th] This report presents the findings of the fifth annual survey of tobacco control leads in local authorities in England | Cancer Research UK and ASH, UK

Cannabis policy and legislation in the Nordic countries

How is cannabis use controlled in the legal systems in the Nordic countries? How do the Nordic legal systems see cannabis as a drug, and how does this affect the cannabis user? The Nordic Welfare Centre´s new report looks at the similarities and differences in legislation and the ways in which the law is enacted in legal practice, police work, and other arenas | Nordic Welfare Centre, Finland and Sweden

National Opioid Pharmacotherapy Statistics Annual Data collection (NOPSAD) 2018

On a snapshot day in 2018, just over 50,000 clients received pharmacotherapy treatment for their opioid dependence at 2,852 dosing points across Australia. There were 3,168 authorised prescribers of opioid pharmacotherapy drugs | AIHW, Australia

Alcohol and other drug treatment services in Australia 2017–18: key findings

In 2017–18, 952 publicly-funded alcohol and other drug treatment services provided just under 210,000 treatment episodes to an estimated 130,000 clients. The four most common drugs that led clients to seek treatment were alcohol (34% of all treatment episodes), amphetamines (25%), cannabis (21%) and heroin (5%). Two-thirds (66%) of all clients receiving treatment were male and the median age of clients was 34 years | AIHW, Australia

National Drug Treatment Reporting System 2011-2017 drug data

Latest figures from the Health Research Board show 63,303 cases* presented for treatment for problem drug use (excluding alcohol) between 2011 and 2017. The number of treated cases increased from 8,361 in 2011 to 9,892 in 2015, and then decreased to 8,922 in 2017 | HRB, Ireland

Examining Australia’s Heaviest Drinkers

This study was undertaken by FARE’s research partner the Centre for Alcohol Policy and Research (CAPR) at La Trobe University and examines the distribution of alcohol consumption in Australia, identifying the top 10% of Australia’s heaviest drinkers and examining their sociodemographic characteristics, alcohol consumption and purchasing practices | FARE, Australia

What’s new about adolescent drinking in the Nordic countries? (PDF)

A report on Nordic studies of adolescent drinking habits in 2000–2018 | Nordic Welfare Centre, Sweden

STAD in Europe: A manual for communities preventing alcohol related harm (PDF)

Binge drinking or heavy episodic drinking1 has a great impact on public safety and health. This manual describes how communities can reduce alcohol related problems by using the STAD approach to limit the availability of alcohol. The manual is based on the original STAD programme and the outcomes from the seven European pilots that were performed within the project STAD in Europe | STAD, Sweden

What’s new about adolescent drinking in the Nordic countries? (PDF)

A report on Nordic studies of adolescent drinking habits in 2000–2018 | Nordic Welfare Centre, Sweden

Changes in Stimulant Use and Related Harms: Focus on Methamphetamine and Cocaine (PDF)

In response to recent reports of increasing harms related to methamphetamine use in Canada, this bulletin summarizes recent changes in stimulant-related harms in Canadian communities. It is intended for a broad audience of health professionals, law enforcement, harm reduction and health service providers, policy makers, and people who use drugs | CCSA, Canada

Denying Revenue or Wasting Money? Assessing the Impact of the Air Campaign Against ‘Drugs Labs’ in Afghanistan (PDF)

This paper conducts a forensic assessment of the aerial campaign against drugs labs to determine whether it fulfilled its primary objective of denying revenue to the insurgency. The paper does this by combining video analysis, high-resolution imagery and in-depth interviews with the lab operators, owners and the rural population most affected by the campaign | LSE, UK

Statistics on NHS Stop Smoking Services in England April 2018 to December 2018

166,880 people set a quit date and at the 4 week follow-up 86,167 people (52 per cent) had successfully quit (self-reported) | NHS Digital, UK

 

 

Home : Terms of use : Contact
Copyright DrugWise©2016